Four years of Horizon Europe research bring an integrated thermochemical and bio-electrochemical pathway towards
AstraZeneca and Daiichi Sankyo’s Enhertu is the first and only HER2-directed medicine to improve
AstraZeneca and Daiichi Sankyo’s Datroway is the only TROP2-directed antibody drug conjugate to prolong
NORTH CHICAGO, Ill., May 27, 2026 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced that the U.S. Food
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present new clinical data from its
Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo®
The U.S. Food and Drug Administration today approved Rasonque (daraxonrasib), a RAS inhibitor for
Researchers sustained the organoids for nearly six years, potentially unlocking longer term studies of
Wearable sensors coupled with artificial intelligence can generate blood pressure readings nearly as well
RAHWAY, N.J. and CAMBRIDGE, MA, August 19, 2026 – Merck (NYSE: MRK), known as
